NeoGenomics, Inc.NEONASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 70% recommend buying.

Consensus Rating

Buy

20 analysts·High coverage

70%

Rating Distribution

Strong Buy

15%

Buy

1365%

Hold

630%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Current price is 0% above analyst consensus — near fair value expected.

Bear Case

$11.00

-9%

Consensus

$12.00

-0%

Bull Case

$14.00

+16%

Price Range20 analysts

Low

Consensus

High

$11.00

$14.00

Current Target

Current Price

$12.06

Above Target

$0.06

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$0.17(7 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+9.42%

EPS+106.88%

FY2028

Rev+10.28%

EPS+26.62%

FY2029

Rev+9.45%

EPS+53.33%

Earnings Surprises

Beat rate:75%(9/12 quarters)

Avg surprise:+108.5%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Oct 28, 2025Leerink Partners

NeoGenomics price target raised to $14 from $12 at Leerink

Target:$14.00

+41.1%from $9.92

Sep 2, 2025Stephens

NeoGenomics price target raised to $11 from $6.50 at Stephens

Target:$11.00

+24.9%from $8.81

Aug 4, 2025Piper Sandler

NeoGenomics price target lowered to $11 from $12 at Piper Sandler

Target:$11.00

+94.0%from $5.67

Jul 30, 2025Morgan Stanley

NeoGenomics price target lowered to $8 from $10 at Morgan Stanley

Target:$8.00

+56.9%from $5.10

Jul 29, 2025Needham

Neogenomics (NEO) PT Lowered to $8 at NeedhamMember Login

Target:$8.00

+52.4%from $5.25

May 6, 2025Piper Sandler

NeoGenomics price target lowered to $12 from $18 at Piper Sandler

Target:$12.00

+53.1%from $7.84

Jan 11, 2025BTIG

NeoGenomics price target lowered to $18 from $21 at BTIG

Target:$18.00

+21.9%from $14.77

Jul 30, 2024Needham

Needham Reiterates Buy Rating on Neogenomics (NEO)

Target:$19.00

+29.8%from $14.64

May 2, 2024BTIG

Neogenomics (NEO) PT Lowered to $21 at BTIG

Target:$21.00

+50.4%from $13.96

Aug 21, 2023Stephens

Stephens Upgrades Neogenomics (NEO) to Overweight

Target:$18.00

+27.8%from $14.08

Aug 17, 2022Piper Sandler

NeoGenomics price target raised to $19 from $13 at Piper Sandler

Target:$19.00

+63.2%from $11.64

Aug 10, 2022Morgan Stanley

Morgan Stanley Maintains Equal-Weight on NeoGenomics, Lowers Price Target to $18

Target:$18.00

+54.4%from $11.66

Aug 10, 2022Goldman Sachs

Goldman Sachs Maintains Buy on NeoGenomics, Raises Price Target to $20

Target:$20.00

+72.6%from $11.59

Aug 10, 2022Needham

Needham Maintains Buy on NeoGenomics, Lowers Price Target to $16

Target:$16.00

+37.0%from $11.68

Apr 28, 2022Raymond James

Raymond James Maintains Outperform on NeoGenomics, Lowers Price Target to $15

Target:$15.00

+43.7%from $10.44

Jun 3, 2021Goldman Sachs

NeoGenomics initiated with a Buy at Goldman Sachs

Target:$55.00

+37.1%from $40.11

May 25, 2021Guggenheim

NeoGenomics price target lowered to $54 from $65 at Truist

Target:$54.00

+37.9%from $39.17

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance